Publications

Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners

Smith CH, Patel S, Woolley RL, Brady MC, Rick CE, Halfpenny R, Rontiris A, Knox-Smith L, Dowling F, Clarke CE, Au P, Ives N, Wheatley K, Sackley CM. Clin Linguist Phon. 2019 Apr 29:1-8. 

Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).

Sackley CM, Smith CH, Rick CE, Brady MC, Ives N, Patel S, Woolley R, Dowling F, Patel R, Roberts H, Jowett S, Wheatley K, Kelly D, Sands G, Clarke CE; PD COMM Pilot Collaborative Group. Pilot Feasibility Study. 2018; 4: 30.

Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease (PD COMM pilot): study protocol for a randomised controlled trial. 

Sackley CM, Smith CH, Rick C, Brady MC, Ives N, Patel R, Roberts H, Dowling F, Jowett S, Wheatley K, Patel S, Kelly D, Sands G, Clarke C. Trials 2014;15(1):213.

 Speech and language therapy for speech problems in Parkinson’s disease.

Herd CP, Tomlinson CL, Deane KHO, Brady MC, Smith CH, Sackley C, Clarke CE. Cochrane Database of Systematic Reviews 2012.

Comparison of speech and language therapy techniques for speech problems in Parkinson’s disease.

Herd CP, Tomlinson CL, Deane KHO, Brady MC, Smith CH, Sackley C, Clarke CE. Cochrane Database of Systematic Reviews 2012.